NCT06177106
SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 5 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Stopped Recruitment suspended Sponsor's reason: Per study team, study will be temporarily suspended with plans to re-open in March 2027.
- Eligibility criteria expanded, about 21 words
- Secondary endpoints: details revised at 3 of 3 entries
- Site details revised
- Notable Primary completion date: Mar 1, 2025 to Mar 1, 2027
- Study completion date: Dec 31, 2025 to Dec 31, 2027
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Jan 1, 2024 to Dec 26, 2023
- Site details revised
- Minor Secondary endpoints: details revised at 1 of 3 entriesv2
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (3)
Arms and interventions
Participants who have a history of squamous cell skin cancer (n=23) will be exposed to acute solar simulated light (SSL). Participants must have sun damage on the forearm, based on a standardized clinical photodamage scale (Hu C, Curiel-Lewandrowski C. Archives of Dermatology, 2011; 147(1):31-36). Each subject will act as his/her own control to minimize inter-subject variability. Subjects from each cohort will be matched based on age and gender.
Participants without a history of squamous cell skin cancer (n=23) will be exposed to acute solar simulated light (SSL). Participants must have sun damage on the forearm, based on a standardized clinical photodamage scale (Hu C, Curiel-Lewandrowski C. Archives of Dermatology, 2011; 147(1):31-36). Each subject will act as his/her own control to minimize inter-subject variability.
Other: Solar Simulated Light
Sites
1 site in 1 country
- University of Arizona Cancer CenterTucson, Arizona, United States